{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:14:23Z","timestamp":1751933663605,"version":"3.40.5"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>The role of thrombotic factors in the pathogenesis and progression of liver fibrosis remains obscure. We aimed to study the relationship between prothrombin G20210A (PT20210) and factor V Leiden (FVL) mutations and the progression of fibrosis and liver function in chronic HCV patients.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>The study included 100 subjects, 88 patients with HCV-related cirrhosis (compensated: 38, decompensated: 50), and 12 controls. Patients with other viral hepatitis or coinfection, inherited metabolic disease, autoimmune hepatitis, hepatic or extrahepatic malignancy, in addition to patients with causes of hypoalbuminemia, elevated bilirubin or prolonged INR not related to cirrhosis were excluded from the study. Relevant clinical data were collected and basic laboratory tests were performed. Liver fibrosis was assessed using APRI and FIB-4 scores. FVL and PT20210 mutations were analyzed.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>FVL and PT20210 mutations were significantly higher in decompensated vs. compensated patients (32% vs. 5.3%, P = 0.001; 20% vs. 5.3%, 0.043, respectively) and absent in controls. Both mutations significantly correlated to the duration of infection, platelet count and fibrosis scores. PT20210 mutation significantly correlated to serum albumin and INR. Both mutations significantly predicted fibrosis scores, especially PT20210 (AUROC: 0.833 for APRI and 0.895 for FIB-4).<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusions<\/jats:title><jats:p>Both mutations are significantly correlated to fibrosis progression and liver profile and could be considered as markers predicting the need for early and different intervention.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0276592","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T18:25:57Z","timestamp":1668104757000},"page":"e0276592","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of prothrombin and factor V Leiden mutations on the progression of fibrosis in patients with chronic hepatitis C"],"prefix":"10.1371","volume":"17","author":[{"given":"Mary","family":"Naguib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Abdel-Razek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2369-4052","authenticated-orcid":true,"given":"Suzanne","family":"Estaphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Abdelsameea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abdel-Samiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2112-3865","authenticated-orcid":true,"given":"Nevine F.","family":"Shafik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"pone.0276592.ref001","unstructured":"Organization WH. Global hepatitis report 2017. World Health Organization, 2017."},{"key":"pone.0276592.ref002","first-page":"ofz040","volume-title":"Open Forum Infectious Diseases","author":"Y Gao","year":"2019"},{"key":"pone.0276592.ref003","unstructured":"Ministry of Health E, El-Zanaty, Associates E, and International I. Egypt Health Issues Survey. Ministry of Health and ICF International Cairo, Egypt and Rockville, MD, USA, 2015."},{"key":"pone.0276592.ref004","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMsr1912628","article-title":"Screening and Treatment Program to Eliminate Hepatitis C in Egypt","volume":"382","author":"I Waked","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"pone.0276592.ref005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MEG.0000000000001250","article-title":"Impact of new direct-acting antiviral drugs on hepatitis C virus-related decompensated liver cirrhosis","volume":"31","author":"M Essa","year":"2019","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"pone.0276592.ref006","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.27835","article-title":"Effect of addition of statins to antiviral therapy in hepatitis C virus\u2013infected persons: results from ERCHIVES","volume":"62","author":"AA Butt","year":"2015","journal-title":"Hepatology (Baltimore, Md)"},{"key":"pone.0276592.ref007","unstructured":"MIH\u0102IL\u0102 R-G, BOICEAN A, and B\u00ceRLU\u021aIU V. The Connection between Hypercoagulability and Fibrogenesis in Chronic Liver Diseases. 2018."},{"journal-title":"Physiology, coagulation pathways","year":"2018","author":"R Chaudhry","key":"pone.0276592.ref008"},{"key":"pone.0276592.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-018-0789-8","article-title":"Thrombin and factor Xa link the coagulation system with liver fibrosis","volume":"18","author":"A Dhar","year":"2018","journal-title":"BMC gastroenterology"},{"key":"pone.0276592.ref010","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hed.24791","article-title":"Activation of transforming growth factor-\u03b21 by thrombin via integrins \u03b1v\u03b21, \u03b1v\u03b23, and \u03b1v\u03b25 in buccal fibroblasts: Suppression by epigallocatechin-3-gallate","volume":"39","author":"JZC Chang","year":"2017","journal-title":"Head & Neck"},{"key":"pone.0276592.ref011","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"T Tsuchida","year":"2017","journal-title":"Nature reviews Gastroenterology & hepatology"},{"key":"pone.0276592.ref012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mehy.2016.06.008","article-title":"The ischemic liver cirrhosis theory and its clinical implications","volume":"94","author":"A. Mancuso","year":"2016","journal-title":"Medical hypotheses"},{"key":"pone.0276592.ref013","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/ATVBAHA.111.242818","article-title":"Mechanistic view of risk factors for venous thromboembolism","volume":"32","author":"PH Reitsma","year":"2012","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"pone.0276592.ref014","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1076029617744320","article-title":"Association of FV G1691A Polymorphism but not A4070G with coronary artery disease","volume":"24","author":"A Amara","year":"2018","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"pone.0276592.ref015","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/17474086.2016.1249364","article-title":"Diagnosis and management of factor V Leiden","volume":"9","author":"E Campello","year":"2016","journal-title":"Expert review of hematology"},{"key":"pone.0276592.ref016","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/17474086.2019.1583555","article-title":"Thrombophilia, risk factors and prevention","volume":"12","author":"E Campello","year":"2019","journal-title":"Expert review of hematology"},{"key":"pone.0276592.ref017","doi-asserted-by":"crossref","first-page":"482. e481","DOI":"10.1016\/j.amjmed.2016.11.016","article-title":"Outcome of patients with venous thromboembolism and factor V Leiden or prothrombin 20210 carrier mutations during the course of anticoagulation","volume":"130","author":"I Tzoran","year":"2017","journal-title":"The American journal of medicine"},{"key":"pone.0276592.ref018","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.3748\/wjg.v22.i18.4427","article-title":"Thrombin activation and liver inflammation in advanced hepatitis C virus infection","volume":"22","author":"E Gonz\u00e1lez-Reimers","year":"2016","journal-title":"World journal of gastroenterology"},{"key":"pone.0276592.ref019","doi-asserted-by":"crossref","first-page":"G171","DOI":"10.1152\/ajpgi.00402.2017","article-title":"Role of the blood coagulation cascade in hepatic fibrosis","volume":"315","author":"A Pant","year":"2018","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"pone.0276592.ref020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"G Garcia-Tsao","year":"2017","journal-title":"Hepatology (Baltimore, Md)"},{"key":"pone.0276592.ref021","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"R Pugh","year":"1973","journal-title":"British journal of surgery"},{"key":"pone.0276592.ref022","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"A Vallet-Pichard","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"key":"pone.0276592.ref023","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"C-T Wai","year":"2003","journal-title":"Hepatology (Baltimore, Md)"},{"key":"pone.0276592.ref024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IJGM.S119301","article-title":"Hepatitis C in Egypt\u2013past, present, and future","volume":"10","author":"A Elgharably","year":"2017","journal-title":"International journal of general medicine"},{"key":"pone.0276592.ref025","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/hep.27296","article-title":"Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C","volume":"60","author":"EA Tsochatzis","year":"2014","journal-title":"Hepatology (Baltimore, Md)"},{"key":"pone.0276592.ref026","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review","volume":"166","author":"O Falade-Nwulia","year":"2017","journal-title":"Annals of internal medicine"},{"key":"pone.0276592.ref027","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/apt.13633","article-title":"Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis","volume":"43","author":"A Majumdar","year":"2016","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"pone.0276592.ref028","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1872-034X.2011.00963.x","article-title":"Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C","volume":"42","author":"K Dik","year":"2012","journal-title":"Hepatology Research"},{"key":"pone.0276592.ref029","first-page":"588","article-title":"Cryptogenetic liver cirrhosis and prothrombotic mutations-A mere association?","volume":"108","author":"MM Monereo","year":"2016","journal-title":"Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva"},{"key":"pone.0276592.ref030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/1110-1415.189345","article-title":"Factor V Leiden mutation in Egyptian patients with deep vein thrombosis","volume":"44","author":"MH Yaman","year":"2016","journal-title":"Tanta Medical Journal"},{"key":"pone.0276592.ref031","doi-asserted-by":"crossref","first-page":"345","DOI":"10.21608\/ejhm.2014.15693","article-title":"Comparative Study on the Effect of Factor V Leiden and Prothrombin Gene Polymorphism in Preeclampsic Cases","volume":"56","author":"RA EL Baz","year":"2014","journal-title":"The Egyptian Journal of Hospital Medicine"},{"key":"pone.0276592.ref032","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12872-016-0456-3","article-title":"Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study","volume":"17","author":"MS Fawzy","year":"2017","journal-title":"BMC cardiovascular disorders"},{"key":"pone.0276592.ref033","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/ejh.ejh_3_19","article-title":"Thrombophilic gene polymorphisms are associated with deep venous thrombosis in a cohort of Egyptian patients","volume":"44","author":"HH Essa","year":"2019","journal-title":"The Egyptian Journal of Haematology"},{"key":"pone.0276592.ref034","first-page":"2011","article-title":"Epidemiology of prothrombin G20210A mutation in the Mediterranean region","volume":"3","author":"MM Jadaon","journal-title":"Mediterranean journal of hematology and infectious diseases"},{"key":"pone.0276592.ref035","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jhep.2015.07.026","article-title":"Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population: The Rotterdam Study","volume":"63","author":"EP Plompen","year":"2015","journal-title":"Journal of hepatology"},{"key":"pone.0276592.ref036","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gut.52.8.1206","article-title":"Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection","volume":"52","author":"M Wright","year":"2003","journal-title":"Gut"},{"key":"pone.0276592.ref037","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1572-0241.2004.04092.x","article-title":"Genetic and acquired thrombotic factors in chronic hepatitis C","volume":"993","author":"Armelle Poujol-Robert","year":"2004","journal-title":"Official journal of the American College of Gastroenterology: ACG"},{"key":"pone.0276592.ref038","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.3748\/wjg.v17.i45.5007","article-title":"Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation","volume":"17","author":"N Maharshak","year":"2011","journal-title":"World journal of gastroenterology: WJG"},{"key":"pone.0276592.ref039","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2893.2006.00790.x","article-title":"The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source","volume":"14","author":"C Goulding","year":"2007","journal-title":"Journal of viral hepatitis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0276592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T19:33:52Z","timestamp":1678563232000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0276592"}},"subtitle":[],"editor":[{"given":"Roza","family":"Chaireti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0276592","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,11,10]]}}}